Results

Total Results: 298 records

Showing results for "6 domains".
Users also searched for: six domains of health care quality

141. Individualizing Cancer Screening in Older Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/individualizing-cancer-screening-older-adults
     March 01, 2021 - range from months to more than 10 years. 5  Older patients also follow varying health trajectories, 6   … at diagnosis, time from treatment, and primary treatment were significant predictors of HRQL in all domains … JAMA . 2001;285(21):2750-6. Reuben DB. … J Urol . 2010;183(6):2206-12. Staquet M, Berzon R, Osoba D, et al.

142. Evidence Summary: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
     November 01, 2022 - The strength of evidence was rated for each major outcome using the domains set out in guidance from … Ann Intern Med . 2019;171(6):406-414. doi:10.7326/M19-0274 21. … Int J Cancer . 2016;138(6):1506-1515. doi:10.1002/ijc.29878 34. … Int J Cancer . 2016;139(6):1241-1250. doi:10.1002/ijc.30172 35. … BJOG . 2014;121(6):700-705. doi:10.1111/1471-0528.12598 101.

143. Q Nxyq7Cwpbuwvt27Sq42 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Q__nXYQ7cWPBuwvt27sQ42
     July 01, 2013 - Diabet Med. 2000;17:720-6. [PMID: 11110505] 5. Agarwal MM, Dhatt GS, Punnose J. … [PMID: 17116182] 6. … Lancet. 2007; 369:750-6. [PMID: 17336651] 70. … 9 pm ol /L JS O G § 48 (0 .4 3– 0. 53 ) 72 (0 .6 3– 0. 79 ) 1. 71 (1 .2 6– 2. 34 ) 0. … Sp ai n 57 8 � 27 .2 Th ird IW C 98 (0 .9 0– 1. 00 ) 89 (0 .8 6– 0. 91 ) 8. 76 (6 .9 6

144. Evidence Summary: Obstructive Sleep Apnea in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary29/obstructive-sleep-apnea-in-adults-screening
     November 15, 2022 - Harms of Treatment Key Question 6. … cited a specific example that a reduction of 1 point (eg, from 3 [high] to 2 [moderate]) on 2 of 7 ESS domains … Am J Epidemiol . 2013;177(9):1006-1014. doi:10.1093/aje/kws342 6. … Chest . 2006;129(6):1459-1467. doi:10.1378/chest.129.6.1459 42. … RCTs reported individual SF-36 domains only) Undetected for all other outcomes 7 Good; 54 fair

145. Archived: C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors
     July 15, 2008 - This article was first published in the Annals of Internal Medicine on October 6, 2009 ( Ann Intern … of CHD deaths occur in persons with cholesterol levels that are lower than the population average. 6 … Our approach incorporated elements previously used by the USPSTF 20 and several domains of the approach … BMJ . 2008;336:924-6. … Arch Intern Med . 2005;165:2454-6.

146. Archived: C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/c-reactive-protein-as-a-risk-factor-for-coronary-heart-disease-a-systematic-review-and-meta-analyses-for-the-us-preventive-services-task-force/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
     July 15, 2008 - This article was first published in the Annals of Internal Medicine on October 6, 2009 ( Ann Intern … of CHD deaths occur in persons with cholesterol levels that are lower than the population average. 6 … Our approach incorporated elements previously used by the USPSTF 20 and several domains of the approach … BMJ . 2008;336:924-6. … Arch Intern Med . 2005;165:2454-6.

147. Secyfgzqgdoqdd8J4Ccvuy (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/SEcYfGZqGdoqdd8j4CCVuy
     May 01, 2008 - The prospective cohort study found that health perceptions (in a minority of self-reported health domains … Mass Screening/ 5. screen$.ti,ab. 6. 4 or 5 7. 3 and 6 8. … Diabet Med. 2000;17:720-6. … Diabetes. 1999;48:2430-6. … BJOG. 2005;112:1461-6.

148. Pdf (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/588/gdart/pdf
     May 01, 2008 - The prospective cohort study found that health perceptions (in a minority of self-reported health domains … Mass Screening/ 5. screen$.ti,ab. 6. 4 or 5 7. 3 and 6 8. … Diabet Med. 2000;17:720-6. … Diabetes. 1999;48:2430-6. … BJOG. 2005;112:1461-6.

149. Archived: Osteoporosis: Screening 2011 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2011
     January 15, 2011 - The FRAX tool was validated in 11 different cohorts, but only 1 of these cohorts included men 6 . … women older than 55 years reported the incidence of vertebral and nonvertebral fractures approximately 6 … ratio for vertebral and nonvertebral fractures increased to a similar degree in both men and women 6 … BMJ . 2008;336:813-6. [PMID: 18334527] National Osteoporosis Foundation.

150. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
     September 15, 2013 - Cancer . 2005;103(6):1147-53. Armstrong K, Quistberg DA, Micco E, Domchek S, Guerra C. … J Natl Cancer Inst Monogr . 2010;2010(41):181-6. … Circulation . 2005;111:650-6. … prevented in 5 years by taking raloxifene instead of placebo, and there is moderate evidence ( P ≥ 6 … they estimate chemoprevention would result in 36 excess life-threatening equivalent events ( P < .6

151. Recommendation: Food Insecurity: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/food-insecurity-screening
     March 11, 2025 - certain populations, such as households with children (particularly those with children younger than 6 … 82% when the screening tool was fully embedded in the reference standard (in most cases, the 18- or 6- … https://innovation.cms.gov/Files/worksheets/ahcm-screeningtool.pdf 6. Alderwick H, Gottlieb LM. … Popul Health Manag . 2020;23(6):422-429. Medline:31910355 doi:10.1089/pop.2019.0158 30. … Pediatr Obes . 2023;18(6):e13023. Medline:36939408 doi:10.1111/ijpo.13023 37.

152. Screening for Food Insecurity: US Preventive Services Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/99YKN27_cW9CRosq9RUMnv
     March 11, 2025 - desire for assistance in ad- dressing a social risk factor and reflects an individual’s priorities.6 … children of caregivers who received general social needs screenings and relevant refer- rals every 6 … 82% when the screening tool was fully embedded in the reference standard (in most cases, the 18- or 6- … Popul Health Manag. 2020;23(6): 422-429. doi:10.1089/pop.2019.0158 30. … Pediatr Obes. 2023;18 (6):e13023. doi:10.1111/ijpo.13023 37.

153. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/v2-menopausal-hormone-therapy-preventive-medicatio
     August 21, 2002 - These tests should examine particular cognitive domains because the evidence indicates that estrogen … Obstet Gynecol 1991;78(6):991-5. 134. Sherwin BB. … Am J Public Health 1988;78:564-6. 163. Jorgensen T. … Fertility & Sterility 1994;62(6 suppl 2):127S-32S. 174. … Control Clin Trials 1998;19(6):604-21. 176. Wren BG.

154. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/menopausal-hormone-therapy-preventive-medication-2002-2005
     August 21, 2002 - These tests should examine particular cognitive domains because the evidence indicates that estrogen … Obstet Gynecol 1991;78(6):991-5. 134. Sherwin BB. … Am J Public Health 1988;78:564-6. 163. Jorgensen T. … Fertility & Sterility 1994;62(6 suppl 2):127S-32S. 174. … Control Clin Trials 1998;19(6):604-21. 176. Wren BG.

155. Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/9K4QQKvhXZNJLCxNX3FkZm
     May 01, 2008 - Potential Harms of Screening or Treatment There are 2 potential domains of harms of screening for and … [PMID: 7294074] 6. Lemen PM, Wigton TR, Miller-McCarthey AJ, Cruikshank DP. … Am J Obstet Gynecol. 1998;178:1251-6. [PMID: 9662309] 7. Marquette GP, Klein VR, Niebyl JR. … Diabetes Care. 1998;21:1803-6. [PMID: 9802724] 9. Southwick RD, Wigton TR. … Obstet Gynecol. 1989;73:562-6. [PMID: 2648224] 17. Langer N, Langer O.

156. Archived: Evidence Summary: Blood Pressure in Adults (Hypertension): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening
     October 15, 2007 - with systolic blood pressure of 130 to 139 mm Hg and diastolic blood pressure of 89 mm Hg or less. 6 … Serious adverse effects were uncommon (overall rate, 11% [range, 6% to 14%]), and the rate of withdrawals … hypertension medications, 3- to 4-wk placebo run-in, then 10 wk of treatment Julius, et al., 2006 6 … Withdrawals Main Results Adverse Events Summary Fogari, et al., 2001 8 6 … Julius, et al., 2006 6 - Candesartan significantly decreased risk for hypertension at the

157. Archived: Evidence Summary: Blood Pressure in Adults (Hypertension): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening-2007
     October 15, 2007 - with systolic blood pressure of 130 to 139 mm Hg and diastolic blood pressure of 89 mm Hg or less. 6 … Serious adverse effects were uncommon (overall rate, 11% [range, 6% to 14%]), and the rate of withdrawals … hypertension medications, 3- to 4-wk placebo run-in, then 10 wk of treatment Julius, et al., 2006 6 … Withdrawals Main Results Adverse Events Summary Fogari, et al., 2001 8 6 … Julius, et al., 2006 6 - Candesartan significantly decreased risk for hypertension at the

158. Individualizing Cancer Screening in Older Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/individualizing-cancer-screening-older-adults
     October 01, 2017 - range from months to more than 10 years. 5  Older patients also follow varying health trajectories, 6   … at diagnosis, time from treatment, and primary treatment were significant predictors of HRQL in all domains … JAMA . 2001;285(21):2750-6. Reuben DB. … J Urol . 2010;183(6):2206-12. Staquet M, Berzon R, Osoba D, et al.

159. Cancer Older Adults (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/cancer_older_adults.pdf
     September 28, 2012 - expectancy can range from months to over 10 years.5 Older patients also follow varying health trajectories,6 … In a constrained primary care environment, services must often be prioritized.6 Little research is available … at diagnosis, time from treatment and primary treatment were significant predictors of HRQL in all domains … JAMA. 2001;285 (21):2750–6. 6. Reuben DB. … J Urol. 2010;183(6):2206–12. 42. Staquet M, Berzon R, Osoba D, et al.

160. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pKa4_DYwzuyD6RDgYzLMbo
     August 22, 2018 - Figure 6. … 12 12 12 12 12 12 12 6 5 5 5 3-6 5 5 5 No. of Sessions 1-6 1 (+1 call) 1-6 1-6 1-6 1-6 1-6 … 1-6 1-6 1 (+3 calls) 1 (+12 calls) 1 (+12 calls) 1 (+12 calls) 1 (+12 calls) 1 (+12 calls) 1 (+12 … Life–BREF. a CTS-2 scales: sexual coercion, physical functioning, psychological aggression. b WHOQOL-BREF domains … Fam Pract. 2005;22(6):617-623. doi:10.1093/fampra/cmi075 17.